| Sensitivity analyses | ||||
| Fetuses affected | Anomalies | |||
| Studies | Sensitivity (95% CI) | Studies | Sensitivity (95% CI) | |
| First‐trimester scan | ||||
| Summary estimate of all included studies | 20 | 37.5 (31.1 to 44.3) | 20 | 39.2 (32.5 to 46.2) |
| Summary estimate of studies that reported complete 2 x 2 tables | 10 | 35.5 (27.0 to 45.0) | 9 | 36.7 (26.2 to 48.6) |
| Summary estimate of studies at low risk of bias ‐ patient selection | 17 | 35.1 (28.6 to 42.2) |
17 | 37.4 (30.1 to 45.3) |
| Summary estimate of studies with low applicability concerns ‐ patient selection | 4 | N/A* | 3 | N/A* |
| Summary estimate of studies at low risk of bias ‐ index test | 20 | 37.5 (31.1 to 44.3) |
20 | 39.2 (32.5 to 46.2) |
| Summary estimate of studies with low applicability concerns ‐ index test | 16 | 40.3 (32.9 to 48.2) |
16 | 42.4 (35.3 to 49.9) |
| Summary estimate of studies at low risk of bias ‐ reference standard | 2 | N/A* | 2 | N/A* |
| Summary estimate of studies with low applicability concerns ‐ reference standard | 20 | 37.5 (31.1 to 44.3) | 20 | 39.2 (32.5 to 46.2) |
| Summary estimate of studies at low risk of bias ‐ flow and timing | 1 | N/A* | 1 | N/A* |
| Summary estimate, excluding studies that used data obtained from birth defect registries | 20 | 37.5 (31.1 to 44.3) | 20 | 39.2 (32.5 to 46.2) |
| Summary estimate, excluding studies with fewer than 10 cases that had the target condition | 17 | 37.6 (30.9 to 41.6) | 18 | 39.3 (32.4 to 46.5) |
| Summary estimate, excluding studies with ≥ 10% lost to follow‐up | 15 | 36.6 (29.1 to 44.7) | 15 | 36.9 (29.0 to 45.5) |
| First + second‐trimester scan | ||||
| Summary estimate of all included studies | 18 | 83.8 (74.7 to 90.1) | 17 | 84.5 (75.8 to 90.5) |
| Summary estimate of studies that reported complete 2 x 2 tables | 10 | 82.6 (71.2 to 90.1) | 8 | 84.0 (71.9 to 91.6) |
| Summary estimate of studies at low risk of bias ‐ patient selection | 15 | 82.4 (71.7 to 89.7) | 14 | 83.0 (72.7 to 90.0) |
| Summary estimate of studies with low applicability concerns ‐ patient selection | 4 | N/A* | 3 | N/A* |
| Summary estimate of studies at low risk of bias ‐ index test | 18 | 83.8 (74.7 to 90.1) | 17 | 84.5 (75.8 to 90.5) |
| Summary estimate of studies with low applicability concerns ‐ index test | 16 | 82.6 (72.3 to 89.7) | 15 | 83.3 (73.3 to 90.1) |
| Summary estimate of studies at low risk of bias ‐ reference standard | 2 | N/A* | 2 | N/A* |
| Summary estimate of studies with low applicability concerns ‐ reference standard | 18 | 83.8 (74.7 to 90.1) | 17 | 84.5 (75.8 to 90.5) |
| Summary estimate of studies at low risk of bias ‐ flow and timing | 1 | N/A* | 1 | N/A* |
| Summary estimate, excluding studies that used data obtained from birth defect registries | 18 | 83.8 (74.7 to 90.1) | 17 | 84.5 (75.8 to 90.5) |
| Summary estimate, excluding studies with fewer than 10 cases that had the target condition | 15 | 83.4 (73.3 to 90.2) | 15 | 84.4 (74.9 to 90.8) |
| Summary estimate, excluding studies with ≥ 10% lost to follow‐up | 14 | 84.3 (74.5 to 90.8) | 14 | 85.2 (76.0 to 91.3) |
| Single second‐trimester scan | ||||
| Summary estimate | 9 | 50.5 (38.5 to 62.4) | 3 | 52.2 (33.2 to 70.7) |
| Summary estimate of studies that reported complete 2 x 2 tables | 5 | 59.3 (42.4 to 74.2) | N/A* | N/A* |
| Summary estimate of studies at low risk of bias ‐ patient selection | 7 | 52.5 (38.6 to 66.1) | N/A* | N/A* |
| Summary estimate of studies with low applicability concerns ‐ patient selection | 8 | 53.2 (40.8 to 65.2) | N/A* | N/A* |
| Summary estimate of studies at low risk of bias ‐ index test | 9 | 50.5 (38.5 to 62.4) | N/A* | N/A* |
| Summary estimate of studies with low applicability concerns ‐ index test | 9 | 50.5 (38.5 to 62.4) | N/A* | N/A* |
| Summary estimate of studies at low risk of bias ‐ reference standard | 4 | N/A* | N/A* | N/A* |
| Summary estimate of studies with low applicability concerns ‐ reference standard | 9 | 50.5 (38.5 to 62.4) | N/A* | N/A* |
| Summary estimate of studies at low risk of bias ‐ flow and timing | 1 | N/A* | N/A* | N/A* |
| Summary estimate, excluding studies that used data obtained from birth defect registries | 8 | 52.2 (33.2 to 70.6) | N/A* | N/A* |
| Summary estimate, excluding studies with fewer than 10 cases that had the target condition | 9 | 50.5 (38.5 to 62.4) | N/A* | N/A* |
| Summary estimate, excluding studies with ≥ 10% lost to follow‐up | 9 | 50.5 (38.5 to 62.4) | N/A* | N/A* |
| *N/A: sensitivity analysis was not performed if four or fewer studies were available. | ||||